This is a request for an ADAMHA Research Scientist Award.
The aims are (1) To examine organizational models of services at the community level and identify their operational differences; to synthesize the evidence on the the cost effectiveness of these models; and to identify key research questions and approaches; (2) To improve measures of service processes and outcomes; (3) To explore innovative data analytic techniques applicable to services research; (4) To examine the cost effectiveness of services for the severely mentally ill through controlled services trials, including (a) an assertive continuous team model compared to a paraprofessional """"""""community companion"""""""" model and a professional clinic-based model, (b) the California capitated """"""""Integrated Service Agency"""""""" model compared to usual services and to services in a """"""""County Interagency Demonstration"""""""" site, (c) six treatment combinations for schizophrenics and their families, (d) additional studies focused on self-help programs, dual-diagnosis programs, and programs using atypical neuroleptics. Additional professional growth objectives are proposed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Award (K05)
Project #
5K05MH000900-04
Application #
2240112
Study Section
Research Scientist Development Review Committee (MHK)
Project Start
1991-04-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Hargreaves, William A; Jerrell, Jeanette M; Lawless, Suzanne Fares et al. (2007) Doing the difficult and dangerous: the community program practice scale. Adm Policy Ment Health 34:138-49
Juarez-Reyes, M G; Shumway, M; Battle, C et al. (1996) Clozapine eligibility: the effect of stringent criteria on ethnic, gender and age subgroups of schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 20:1341-52
Hargreaves, W A; Shumway, M (1996) Pharmacoeconomics of antipsychotic drug therapy. J Clin Psychiatry 57 Suppl 9:66-76
Juarez-Reyes, M G; Shumway, M; Battle, C et al. (1995) Effects of stringent criteria on eligibility for clozapine among public mental health clients. Psychiatr Serv 46:801-6
Johnson, B A; Aswad, D W (1985) Enzymatic protein carboxyl methylation at physiological pH: cyclic imide formation explains rapid methyl turnover. Biochemistry 24:2581-6